四川能投發展(01713.HK):謝佩樨獲提名重選為執行董事
格隆匯7月16日丨四川能投發展(01713.HK)發佈公吿,熊林先生、李暉先生及謝佩樨女士獲提名重選為執行董事;韓春紅女士及李彧女士獲提名重選為非執行董事;梁紅女士及呂豔女士獲提名選舉為非執行董事;郭建江先生、何真女士及王鵬先生獲提名重選為獨立非執行董事;及李堅教授獲提名選舉為獨立非執行董事。
閆禕先生、唐洪先生及傅若雪女士獲提名重選為股東代表監事;及彭宇先生獲提名選舉為股東代表監事。李佳女士獲重選為職工代表監事;及廖駿先生獲選舉為職工代表監事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.